MT1-MMP-mediated basement membrane remodeling modulates renal development

Experimental Cell Research

Volumn 316, Issue 17, 2010, Pages 2993-3005

  Riggins, Karen S ^b   Mernaugh, Glenda ^b   Su, Yan ^a   Quaranta, Vito ^a   Koshikawa, Naohiko ^c   Seiki, Motoharu ^c   Pozzi, Ambra ^a,b,d   Zent, Roy ^a,b,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basement membrane; Branching morphogenesis; Kidney; Matrix metalloproteinases

Indexed keywords

COLLAGEN TYPE 4; ENTACTIN; GELATINASE A; GELATINASE B; LAMININ; LAMININ GAMMA1; MATRIX METALLOPROTEINASE; PERLECAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IN VITRO STUDY; KIDNEY DEVELOPMENT; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WILD TYPE; ANIMAL; BASEMENT MEMBRANE; CELL MOTION; CYTOLOGY; DEFICIENCY; GROWTH, DEVELOPMENT AND AGING; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; BASEMENT MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR MATRIX; KIDNEY; MATRIX METALLOPROTEINASE 14; MICE; MICE, KNOCKOUT; PHENOTYPE;

EID: 77956919257     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.003     Document Type: Article

References (53)

1. Costantini F., Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 2010, 18:698-712.
2. Miner J. Renal basement membrane components. Kidney Int. 1999, 56:2016-2024.
3. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell Physiol. 2006, 206:1-8.
4. Lelongt B.T., Trugnan G., Murphy G., Ronco P.M. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell Biol. 1997, 136:1363-1373.
5. Ota K., Kanwar Y.S., Yang Q., Wada J., Kashihara N., Tian Y., Wallner E.I. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. Am. J. Physiol. 1999, 277:934-947.
6. Ikeda T., Itoh T., Gomi H., Nakao S., Suzuki T., Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 1997, 272:22389-22392.
7. Andrews K., Betsuyaku T., Rogers S., Shipley J.M., Senior R.M., Miner J.H. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am. J. Pathol. 2000, 157:303-311.
8. Zeisberg M., Khurana M., Rao V.H., Cosgrove D., Rougier J.P., Werner M.C., Shield C.F., Werb Z., Kalluri R. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med. 2006, 3.
9. Flamant M., Placier S., Dubroca C., Esposito B., Lopes I., Chatziantoniou C., Tedgui A., Dussaule J.C., Lehoux S. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 2007, 50:212-218.
10. Wielockx B., Lambert V., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noël A., Rakic J.M. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 2003, 17:2290-2292.
11. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell Physiol. 2006, 206:1-8.
12. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003, 194:1-11.
13. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 2001, 153:893-904.
14. Belkin A., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 2001, 276:18415-18422.
15. Rozanov D., Hahn-Dantona E., Strickland D.K., Strongin A.Y. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J. Biol. Chem. 2004, 279:4260-4268.
16. Deryugina E., Ratnikov B.I., Postnova T.I., Rozanov D.V., Strongin A.Y. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 2002, 277:9749-9756.
17. Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 2003, 278:40764-40770.
18. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., Ward J.M., Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999, 99:81-92.
19. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U S A 2000, 97:4052-4057.
20. Szabova L., Yamada S.S., Wimer H., Chrysovergis K., Ingvarsen S., Behrendt N., Engelholm L.H., Holmbeck K. MT1-MMP and type II collagen specify skeletal stem cells and their bone and cartilage progeny. J. Bone Miner. Res. 2009, 24:1905-1916.
21. Oblander S., Zhou Z., Gálvez B.G., Starcher B., Shannon J.M., Durbeej M., Arroyo A.G., Tryggvason K., Apte S.S. Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev. Biol. 2005, 277:255-269.
22. Atkinson J., Holmbeck K., Yamada S., Birkedal-Hansen H., Parks W.C., Senior R.M. Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. Dev. Dyn. 2005, 232:1079-1090.
23. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U S A 2000, 97:4052-4057.
24. Guadamillas M.C., Gonzalo P., Hernández-Riquer M.V., Pollán A., Grande-García A., Bartolomé R.A., Vasanji A., Ambrogio C., Chiarle R., Teixidó J., Risteli J., Apte S.S., del Pozo M.A., Arroyo A.G. MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. Dev. Cell 2010, 18:77-89.
25. Trugnan G., Legallicier B., Murphy G., Lelongt B., Ronco P. Expression of the Type IV collagenase system during mouse kidney development and tubule segmentation. J. Am. Soc. Nephrol. 2001, 12:2358-2369.
26. Koshikawa N., Schenk S., Moeckel G., Sharabi A., Miyazaki K., Gardner H., Zent R., Quaranta V. Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology. FASEB J. 2004, 18:364-366.
27. Irie K., Komori K., Seiki M., Tsuruga E., Sakakura Y., Kaku T., Yajima T. Impaired alveolization in mice deficient in membrane-type matrix metalloproteinase 1 (MT1-MMP). Med. Mol. Morphol. 2005, 38:43-46.
28. Boyle S., Shioda T., Perantoni A.O., de Caestecker M. Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev. Dyn. 2007, 236:2321-2330.
29. Zent R., Bush K.T., Pohl M.L., Quaranta V., Koshikawa N., Wang Z., Kreidberg J.A., Sakurai H., Stuart R.O., Nigam S.K. Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development. Dev. Biol. 2001, 238:289-302.
30. Pozzi A., Moberg P.E., Miles L.A., Wagner S., Soloway P., Gardner H.A. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. U S A 2000, 97:2202-2207.
31. Li S., Bordoy R., Stanchi F., Moser M., Braun A., Kudlacek O., Wewer U.M., Yurchenco P.D., Fassler R. PINCH1 regulates cell-matrix and cell-cell adhesions, cell polarity and cell survival during the peri-implantation stage. J. Cell Sci. 2005, 118:2913-2921.
32. Yurchenco P.D., Cheng Y.S., Ruben G.C. Self-assembly of a high molecular weight basement membrane heparan sulfate proteoglycan into dimers and oligomers. J. Biol. Chem. 1987, 262:17668-17676.
33. Husted R.F., Hayashi M., Stokes J.B. Characteristics of papillary collecting duct cells in primary culture. Am. J. Physiol. 1988, 255:F1160-F1169.
34. Atkinson S.J., Crabbe T., Cowell S., Ward R.V., Butler M.J., Sato H., Seiki M., Reynolds J.J., Murphy G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 1995, 270:30479-30485.
35. Chen D., Roberts R., Pohl M., Nigam S., Kreidberg J., Wang Z., Heino J., Ivaska J., Coffa S., Harris R.C., Pozzi A., Zent R. Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesis. Am. J. Physiol. Renal Physiol. 2004, 287:602-611.
36. Takino T., Sato H., Miyamori H. Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci. 2005, 96:212-217.
37. H.a.M., Nagase G. Tailoring TIMPs for selective metalloproteinase inhibition 2008, Springer Science, New York.
38. Rodriguez D., Morrison C.J., Overall C.M. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 2010, 1803:39-54.
39. Cebrian C., Lu B.C., Chi X., Kuure S., Kuo R., Bates C.M., Arber S., Hassell J., MacNeil L., Hoshi M., Jain S., Asai N., Takahashi M., Schmidt-Ott K.M., Barasch J., D'Agati V., Costantini F. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat. Genet. 2009, 41:1295-1302.
40. Shen L., Pichel J.G., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., Sariola H., Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996, 382:73-76.
41. D'Agati V., Schuchardt A., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383.
42. Klein R.D., Moore M.W., Fariñas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996, 382:76-79.
43. Silos-Santiago I., Sánchez M.P., Frisén J., He B., Lira S.A., Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996, 382:70-73.
44. Yana I., Hotary K.B., Sabeh F., Li X.Y., Holmbeck K., Birkedal-Hansen H., Allen E.D., Hiraoka N., Weiss S.J. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 2002, 195:295-308.
45. Hotary K., Allen E.D., Brooks P.C., Datta N.S., Long M.W., Weiss S.J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45.
46. Myers C., Rebustini I.T., Lassiter K.S., Surmak A., Szabova L., Holmbeck K., Pedchenko V., Hudson B.G., Hoffman M.P. MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev. Cell 2009, 17:482-493.
47. Koshikawa N., Mizushima H., Minegishi T., Iwamoto R., Mekada E., Seiki M. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor. Cancer Res. 2010, 70:6093-6103.
48. Mimura T., Han K.Y., Onguchi T., Chang J.H., Kim T.I., Kojima T., Zhou Z., Azar D.T. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J. Vasc. Res. 2009, 46:541-550.
49. Basile J.R., Holmbeck K., Bugge T.H., Gutkind J.S. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 2007, 282:6899-6905.
50. Tam E.M., Morrison C.J., Wu Y.I., Stack M.S., Overall C.M. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. U S A 2004, 101:6917-6922.
51. [51] M. d'Ortho, Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., Murphy, G., Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases., 250 3 (1997) 751-757.
52. Chen P., Parks W.C. Role of matrix metalloproteinases in epithelial migration. J. Cell Biochem. 2009, 108:1233-1243.
53. Genis L., Galvez B.G., Gonzalo P., Arroyo A.G. MT1-MMP: universal or particular player in angiogenesis?. Cancer Metastasis Rev. 2006, 25:77-86.